Risk factors for hilar cholangiocarcinoma: A case-control study in China

被引:69
作者
Cai, Wen-Ke [1 ]
Sima, Hui [1 ]
Chen, Ben-Dong [1 ]
Yang, Guang-Shun [1 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Biliary Surg 2, Shanghai 200438, Peoples R China
关键词
Hilar cholangiocarcinoma; Choledocholithiasis; Hepatitis B virus; Hepatitis C virus; Liver fluke; PRIMARY SCLEROSING CHOLANGITIS; HEPATITIS-B-VIRUS; OPISTHORCHIS-VIVERRINI INFECTION; CARCINOGENIC PARASITE INFECTION; CLONORCHIS-SINENSIS INFECTION; INTRAHEPATIC CHOLANGIOCARCINOMA; UNITED-STATES; NATURAL-HISTORY; BILIARY-TRACT; LIVER;
D O I
10.3748/wjg.v17.i2.249
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
AIM: To study the association between hilar cholangiocarcinoma (HC) and pre-existing medical conditions. METHODS: Three hundred and thirteen HC patients admitted to the Eastern Hepatobiliary Surgery Hospital (Shanghai, China) in 2000-2005 and 608 healthy controls were enrolled in this study. Association between HC and pre-existing medical conditions was studied with their adjusted odds ratio (OR) calculated by logistic regression analysis. RESULTS: The prevalence of choledocholithiasis (adjusted OR = 2.704, P = 0.039), hepatolithiasis (adjusted OR = 3.278, P = 0.018), cholecystolithiasis (adjusted OR = 4.499, P < 0.0001), cholecystectomy (adjusted OR = 7.012, P = 0.004), biliary ascariasis (adjusted OR = 7.188, P = 0.001), liver fluke (adjusted OR = 10.088, P = 0.042) and liver schistosomiasis (adjusted OR = 9.913, P = 0.001) was higher in HC patients than in healthy controls. CONCLUSION: Biliary tract stone disease (choledocholithiasis, hepatolithiasis, cholecystolithiasis) and parasitic liver disease (biliary ascariasis, liver fluke, liver schistosomiasis) are the risk factors for HC in Chinese population. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 41 条
[1]
Parasitic infections and hepatic neoplasia [J].
Abdel-Rahim, AY .
DIGESTIVE DISEASES, 2001, 19 (04) :288-291
[2]
Ahrendt S A, 2001, Clin Liver Dis, V5, P191, DOI 10.1016/S1089-3261(05)70161-6
[3]
SERUM ANTIBODY-RESPONSE TO OPISTHORCHIS-VIVERRINI ANTIGEN AS A MARKER FOR OPISTHORCHIASIS-ASSOCIATED CHOLANGIOCARCINOMA [J].
AKAI, PS ;
PUNGPAK, S ;
CHAICUMPA, W ;
VIROJ, K ;
BUNNAG, D ;
BEFUS, AD .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (04) :471-474
[4]
Andoh H, 2004, J GASTROENTEROL, V39, P64, DOI [10.1007/s00535-004-1464-0, 10.1007/s00535-003-1249-x]
[5]
DETECTION OF HEPATITIS-B VIRUS-DNA IN HEPATOCYTES, BILE-DUCT EPITHELIUM, AND VASCULAR ELEMENTS BY INSITU HYBRIDIZATION [J].
BLUM, HE ;
STOWRING, L ;
FIGUS, A ;
MONTGOMERY, CK ;
HAASE, AT ;
VYAS, GN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (21) :6685-6688
[6]
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis [J].
Broome, U ;
Olsson, R ;
Loof, L ;
Bodemar, G ;
Hultcrantz, R ;
Danielsson, A ;
Prytz, H ;
SandbergGertzen, H ;
Wallerstedt, S ;
Lindberg, G .
GUT, 1996, 38 (04) :610-615
[7]
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis [J].
Burak, K ;
Angulo, P ;
Pasha, TM ;
Egan, K ;
Petz, J ;
Lindor, KD .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (03) :523-526
[8]
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study [J].
Chalasani, N ;
Baluyut, A ;
Ismail, A ;
Zaman, A ;
Sood, G ;
Ghalib, R ;
McCashland, TM ;
Reddy, KR ;
Zervos, X ;
Anbari, MA ;
Hoen, H .
HEPATOLOGY, 2000, 31 (01) :7-11
[9]
Chen Ru-Fu, 2005, Hepatobiliary Pancreat Dis Int, V4, P71
[10]
Cholangiocarcinoma and Clonorchis sinensis infection:: A case-control study in Korea [J].
Choi, Dongil ;
Lim, Jae Hoon ;
Lee, Kyu Taek ;
Lee, Jong Kyun ;
Choi, Seong Ho ;
Heo, Jin Seok ;
Jang, Kee-Taek ;
Lee, Nam Yong ;
Kim, Seonwoo ;
Hong, Sung-Tae .
JOURNAL OF HEPATOLOGY, 2006, 44 (06) :1066-1073